FSSNX | VSMSX | FSSNX / VSMSX | |
Total Expense Ratio | 0.03 | 0.03 | 83% |
Annual Report Gross Expense Ratio | 0.03 | 0.03 | 83% |
Fund Existence | 14 years | 15 years | - |
Gain YTD | 11.236 | 3.239 | 347% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 5000000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 28.4B | 4.71B | 603% |
Annual Yield % from dividends | 0.82 | 1.43 | 57% |
Returns for 1 year | 9.17 | 0.09 | 10,001% |
Returns for 3 years | 46.51 | 28.48 | 163% |
Returns for 5 years | 56.90 | 58.83 | 97% |
Returns for 10 years | 107.79 | 119.07 | 91% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
FBDIX | 161.38 | 1.46 | +0.91% |
Franklin Biotechnology Discovery A | |||
VGIAX | 116.58 | 0.51 | +0.44% |
Vanguard Growth & Income Adm | |||
WWSCX | 17.88 | 0.04 | +0.22% |
Keeley Small Cap Fund C | |||
RIVIX | 20.08 | -0.05 | -0.25% |
American Funds International Vntg R-3 | |||
OEQAX | 10.06 | -0.10 | -0.98% |
Oaktree Emerging Markets Equity A |